Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...
Is Bitcoin (BTC) Ready for $100,000? Solana (SOL) Skyrockets, But in Wrong Way, Shiba Inu (SHIB): Is There Any Hope?